The American Heart Association is emphasizing that coronary artery calcium (CAC) testing is not appropriate for everyone, despite growing public interest in the scan. A CAC test is a quick, noninvasive CT scan that detects calcium deposits in the coronary arteries, which can be an early sign of plaque buildup, or atherosclerosis. The resulting calcium score provides individuals and their healthcare professionals with additional information about future risk of cardiovascular disease or events such as heart attack or stroke.
The scan takes about 10 to 15 minutes, does not require injected contrast dye, and uses a low dose of radiation. However, the Association stresses that CAC testing is not necessary for everyone. The American Heart Association/American College of Cardiology dyslipidemia guideline supports selective use of CAC scoring, particularly when a person's cardiovascular risk falls in a middle range and there is uncertainty about whether to begin or intensify cholesterol-lowering treatment. The 2026 guideline encourages the use of the American Heart Association’s PREVENT™ equations as the starting point for estimating cardiovascular risk and identifies CAC as a tool to refine treatment decisions when the answer remains unclear.
“The American Heart Association does not recommend broad based use of the CAC test for screening. The Association recommends it as a decision aid for people at borderline or intermediate risk for atherosclerotic cardiovascular disease – but only when the decision about whether to use drug therapy to lower risk is uncertain. It is a tiebreaker test,” said Manesh R. Patel, M.D., FAHA, volunteer president of the American Heart Association and chief of the division of cardiology at Duke University School of Medicine.
Recent research highlights that CAC provides the greatest value when the result can change a treatment decision. New studies have found that modern risk estimation with the Association’s PREVENT equations can effectively identify coronary artery disease risk for many people, while adding CAC information can be particularly useful for those in borderline (3% to less than 5%) and intermediate (5% to less than 10%) risk groups. The guidelines recommend using calcium findings to help inform decisions on the use of statins for men age 40 and older and women age 45 and older with borderline or intermediate 10-year risk of heart attack or stroke.
Four things consumers should know about CAC: First, the first step is a conversation, not necessarily a scan. People should talk with their healthcare professional about their overall cardiovascular risk and whether knowing their CAC score would actually change what they do next. It generally isn't useful when cardiovascular risk is already very low or when the appropriate treatment is already clear, such as for those with diabetes or very high cholesterol. It is also generally not helpful if someone has already had a heart attack or cardiac catheterization. Second, the scan looks for evidence of plaque already in the coronary arteries. The scan, which is typically not covered by health insurance and can cost the patient $100 to $400, detects and measures calcium associated with plaque buildup. Third, it is a potential decision-making tool, not an annual screening test. The Association recommends that the “first prescription” for prevention should be lifestyle modification, including avoiding smoking and tobacco use and emphasizing a healthy diet, exercise and sleep as defined by the Association’s Life’s Essential 8™. Fourth, a score of zero is reassuring, but it isn't a lifetime “all clear.” A CAC score of zero doesn’t rule out noncalcified plaque. Other factors that impact cardiovascular disease risk, including diabetes, smoking, very high cholesterol and a strong family history of premature heart disease, still matter.
For more information, the Association offers coronary artery calcium testing (CAC test) from the American Heart Association and the Life's Essential 8™ My Life Check Calculator to learn your own heart health score at home. Additional resources include Catalyzing CAC Testing to Transform Heart Health and the About the PREVENT™ Equations. The 2026 ACC/American Heart Association cholesterol guideline news release provides further context. Consumers can also refer to the American Heart Association Cholesterol-Lowering Medications Guide and the American Heart Association Cholesterol Tools and Resources Page.

